To investigate the influence of cladribine on LPS-induced monocyte activation, isolated CD14+-monocytes were incubated with or without 100 ng/mL of LPS for 24 h, in the presence or absence of the mean concentration of cladribine found in the blood of treated MS patients (0.1 μM). This evidence concerns the gene CD14 and myeloid sarcoma.